COVID-19: Coronavirus Vaccine Deployment Spread To 36-37 Years As Indian Variant Cases Double In One Week

0
12
COVID-19: Coronavirus Vaccine Deployment Spread To 36-37 Years As Indian Variant Cases Double In One Week


People aged 36 and 37 will be offered the coronavirus vaccine this week, Matt Hancock said.

Speaking to MPs in the House of Commons, the Health Secretary announced the extension of the vaccine rollout after people aged 38 and 39 were able to reserve a vaccine last week.

He urges people to receive the jab as a case of the Indian variant COVID continue to increase.

Live updates as lockdown made easier in England, Wales and Scotland

Please use Chrome browser for a more accessible video player

Hancock: Vaccines acting against the Indian variant

He said there were now more than 2,000 confirmed cases of the variant in the UK – including 483 in Bolton and Blackburn with Darwen.

Cases had doubled last week – to 19 people Bolt hospitalized with the variant and eight in Blackburn.

Mr Hancock revealed there were 86 local authorities where there were five or more confirmed cases of the Indian variant and said surge tests would be carried out in Bedford following an increase in cases.

In Bolton, a rapid response team has been “deployed” to the region, including the deployment of 50 additional vaccinators, the opening of two new vaccination centers and six screening centers.

The vaccination rate there tripled over the weekend, with 6,200 people receiving a vaccine.

Subscribe to the daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Further restrictions were lifted on Monday, with hospitality allowed to open up indoor areas, outdoor gatherings for up to 30 people, and international travel allowed.

The total number of people who received their first dose of the vaccine now stands at 36,704,672, while 20,287,403 people have received two doses.

Guidelines recently changed on the AstraZeneca vaccine, with those under 40 being offered an alternative after a small number of blood clots were reported.

However, on Sunday Professor Adam Finn of the University of Bristol and a member of the Joint Committee on Vaccination and Immunization (JCVI) was asked if the JCVI would reconsider the recommendation that people under 40 should be offered alternatives to the Oxford-AstraZeneca jab if that means it could speed up the rollout.

“Yes, absolutely, it’s on the agenda, and if necessary, it’s something that could be done,” he said.

“When we expressed a preference for the non-AstraZeneca vaccines for this age group, it was done on a very tentative basis on the basis of everything is perfectly fine.

Please use Chrome browser for a more accessible video player

The government “has clear guidelines” on the deployment of the jab

“And if the evidence shows that the risk / benefit ratio for people in their 30s is to be offered this vaccine, then absolutely that recommendation will be changed.

“At the moment, we don’t think it’s necessary, but it may well become a recommendation in the future. “

The UK reported five more deaths and 1,979 new cases of the coronavirus on Monday.

LEAVE A REPLY

Please enter your comment!
Please enter your name here